GEBERIT AG-REG (GBRA.DE) Stock Fundamental Analysis
Europe - FRA:GBRA - CH0030170408 - Common Stock
649.2 EUR
+4.2 (+0.65%)
We assign a fundamental rating of 6 out of 10 to GBRA. GBRA was compared to 23 industry peers in the Building Products industry. GBRA has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. GBRA is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year GBRA was profitable.
GBRA had a positive operating cash flow in the past year.
Each year in the past 5 years GBRA has been profitable.
In the past 5 years GBRA always reported a positive cash flow from operatings.
1.2 Ratios
GBRA's Return On Assets of 26.67% is amongst the best of the industry. GBRA outperforms 100.00% of its industry peers.
Looking at the Return On Equity, with a value of 77.28%, GBRA belongs to the top of the industry, outperforming 95.65% of the companies in the same industry.
GBRA has a better Return On Invested Capital (36.62%) than 95.65% of its industry peers.
GBRA had an Average Return On Invested Capital over the past 3 years of 22.59%. This is significantly above the industry average of 10.74%.
The last Return On Invested Capital (36.62%) for GBRA is above the 3 year average (22.59%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 26.67% | ||
| ROE | 77.28% | ||
| ROIC | 36.62% |
ROA(3y)18.12%
ROA(5y)18.3%
ROE(3y)46.59%
ROE(5y)42.24%
ROIC(3y)22.59%
ROIC(5y)22.79%
1.3 Margins
GBRA has a better Profit Margin (19.42%) than 95.65% of its industry peers.
GBRA's Profit Margin has declined in the last couple of years.
The Operating Margin of GBRA (25.29%) is better than 100.00% of its industry peers.
GBRA's Operating Margin has been stable in the last couple of years.
GBRA has a better Gross Margin (73.19%) than 100.00% of its industry peers.
In the last couple of years the Gross Margin of GBRA has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 25.29% | ||
| PM (TTM) | 19.42% | ||
| GM | 73.19% |
OM growth 3Y-2.12%
OM growth 5Y0.15%
PM growth 3Y-3.95%
PM growth 5Y-1.61%
GM growth 3Y0.77%
GM growth 5Y0.21%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), GBRA is creating value.
The number of shares outstanding for GBRA has been reduced compared to 1 year ago.
Compared to 5 years ago, GBRA has less shares outstanding
The debt/assets ratio for GBRA is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 8.83 indicates that GBRA is not in any danger for bankruptcy at the moment.
GBRA has a Altman-Z score of 8.83. This is amongst the best in the industry. GBRA outperforms 95.65% of its industry peers.
The Debt to FCF ratio of GBRA is 2.01, which is a good value as it means it would take GBRA, 2.01 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.01, GBRA belongs to the top of the industry, outperforming 86.96% of the companies in the same industry.
A Debt/Equity ratio of 0.94 indicates that GBRA is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.94, GBRA is not doing good in the industry: 60.87% of the companies in the same industry are doing better.
Even though the debt/equity ratio score it not favorable for GBRA, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.94 | ||
| Debt/FCF | 2.01 | ||
| Altman-Z | 8.83 |
ROIC/WACC7.6
WACC4.82%
2.3 Liquidity
GBRA has a Current Ratio of 1.30. This is a normal value and indicates that GBRA is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of GBRA (1.30) is worse than 69.57% of its industry peers.
A Quick Ratio of 0.83 indicates that GBRA may have some problems paying its short term obligations.
The Quick ratio of GBRA (0.83) is comparable to the rest of the industry.
GBRA does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.83 |
3. Growth
3.1 Past
GBRA shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.45%.
GBRA shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.08% yearly.
Looking at the last year, GBRA shows a small growth in Revenue. The Revenue has grown by 0.05% in the last year.
The Revenue has been growing slightly by 0.02% on average over the past years.
EPS 1Y (TTM)-1.45%
EPS 3Y-5.14%
EPS 5Y0.08%
EPS Q2Q%-4.75%
Revenue 1Y (TTM)0.05%
Revenue growth 3Y-3.75%
Revenue growth 5Y0.02%
Sales Q2Q%-51.98%
3.2 Future
GBRA is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.75% yearly.
The Revenue is expected to grow by 4.55% on average over the next years.
EPS Next Y5.09%
EPS Next 2Y6.74%
EPS Next 3Y7.04%
EPS Next 5Y7.75%
Revenue Next Year2.38%
Revenue Next 2Y3.47%
Revenue Next 3Y3.94%
Revenue Next 5Y4.55%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 34.10, the valuation of GBRA can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of GBRA is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.90, GBRA is valued a bit more expensive.
A Price/Forward Earnings ratio of 29.45 indicates a quite expensive valuation of GBRA.
GBRA's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.36, GBRA is valued a bit more expensive.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.1 | ||
| Fwd PE | 29.45 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GBRA indicates a slightly more expensive valuation: GBRA is more expensive than 73.91% of the companies listed in the same industry.
GBRA's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 30.01 | ||
| EV/EBITDA | 15.94 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of GBRA may justify a higher PE ratio.
PEG (NY)6.69
PEG (5Y)437.85
EPS Next 2Y6.74%
EPS Next 3Y7.04%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.13%, GBRA has a reasonable but not impressive dividend return.
GBRA's Dividend Yield is a higher than the industry average which is at 3.85.
GBRA's Dividend Yield is comparable with the S&P500 average which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.13% |
5.2 History
The dividend of GBRA has a limited annual growth rate of 3.24%.
Dividend Growth(5Y)3.24%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
GBRA pays out 45.67% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of GBRA is growing, but earnings are growing more, so the dividend growth is sustainable.
DP45.67%
EPS Next 2Y6.74%
EPS Next 3Y7.04%
FRA:GBRA (10/6/2025, 7:00:00 PM)
649.2
+4.2 (+0.65%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)
Earnings (Next)
Inst Owners41.77%
Inst Owner ChangeN/A
Ins Owners0.51%
Ins Owner ChangeN/A
Market Cap22.02B
Analysts52.59
Price Target606.52 (-6.57%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.13% |
Yearly Dividend13.56
Dividend Growth(5Y)3.24%
DP45.67%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.29%
Min EPS beat(2)-12.75%
Max EPS beat(2)-3.83%
EPS beat(4)0
Avg EPS beat(4)-7.18%
Min EPS beat(4)-12.75%
Max EPS beat(4)-3.83%
EPS beat(8)3
Avg EPS beat(8)-2.74%
EPS beat(12)5
Avg EPS beat(12)0.4%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.41%
Min Revenue beat(2)-4.21%
Max Revenue beat(2)-0.61%
Revenue beat(4)1
Avg Revenue beat(4)-1.04%
Min Revenue beat(4)-4.21%
Max Revenue beat(4)3.04%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.86%
PT rev (3m)1.85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-0.33%
EPS NY rev (3m)-0.78%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.22%
Revenue NY rev (3m)-0.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.1 | ||
| Fwd PE | 29.45 | ||
| P/S | 4.31 | ||
| P/FCF | 30.01 | ||
| P/OCF | 23.67 | ||
| P/B | 17.17 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.94 |
EPS(TTM)19.04
EY2.93%
EPS(NY)22.04
Fwd EY3.4%
FCF(TTM)21.63
FCFY3.33%
OCF(TTM)27.42
OCFY4.22%
SpS150.46
BVpS37.81
TBVpS-4
PEG (NY)6.69
PEG (5Y)437.85
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 26.67% | ||
| ROE | 77.28% | ||
| ROCE | 44.61% | ||
| ROIC | 36.62% | ||
| ROICexc | 39.65% | ||
| ROICexgc | 84.48% | ||
| OM | 25.29% | ||
| PM (TTM) | 19.42% | ||
| GM | 73.19% | ||
| FCFM | 14.38% |
ROA(3y)18.12%
ROA(5y)18.3%
ROE(3y)46.59%
ROE(5y)42.24%
ROIC(3y)22.59%
ROIC(5y)22.79%
ROICexc(3y)25.57%
ROICexc(5y)26.4%
ROICexgc(3y)57.33%
ROICexgc(5y)62.93%
ROCE(3y)27.59%
ROCE(5y)27.83%
ROICexcg growth 3Y-11.76%
ROICexcg growth 5Y2.08%
ROICexc growth 3Y-6.14%
ROICexc growth 5Y3.09%
OM growth 3Y-2.12%
OM growth 5Y0.15%
PM growth 3Y-3.95%
PM growth 5Y-1.61%
GM growth 3Y0.77%
GM growth 5Y0.21%
F-Score7
Asset Turnover1.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.94 | ||
| Debt/FCF | 2.01 | ||
| Debt/EBITDA | 0.83 | ||
| Cap/Depr | 115.76% | ||
| Cap/Sales | 3.85% | ||
| Interest Coverage | 43.55 | ||
| Cash Conversion | 63.7% | ||
| Profit Quality | 74.05% | ||
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.83 | ||
| Altman-Z | 8.83 |
F-Score7
WACC4.82%
ROIC/WACC7.6
Cap/Depr(3y)119.94%
Cap/Depr(5y)111.63%
Cap/Sales(3y)5.76%
Cap/Sales(5y)5.44%
Profit Quality(3y)99.53%
Profit Quality(5y)105.03%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.45%
EPS 3Y-5.14%
EPS 5Y0.08%
EPS Q2Q%-4.75%
EPS Next Y5.09%
EPS Next 2Y6.74%
EPS Next 3Y7.04%
EPS Next 5Y7.75%
Revenue 1Y (TTM)0.05%
Revenue growth 3Y-3.75%
Revenue growth 5Y0.02%
Sales Q2Q%-51.98%
Revenue Next Year2.38%
Revenue Next 2Y3.47%
Revenue Next 3Y3.94%
Revenue Next 5Y4.55%
EBIT growth 1Y-1.34%
EBIT growth 3Y-5.79%
EBIT growth 5Y0.17%
EBIT Next Year21.81%
EBIT Next 3Y11.03%
EBIT Next 5Y9.87%
FCF growth 1Y18.05%
FCF growth 3Y-7.7%
FCF growth 5Y-0.45%
OCF growth 1Y13.79%
OCF growth 3Y-5.33%
OCF growth 5Y0.32%